Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|---|
1 | 2 | ||||
Pruritus | Pruritus | 1.6% | x | x | |
Folliculitis | Folliculitis | 0.3% | x | x | |
Erythema | Erythema | 0.2% | x | x | |
Dermatitis | Rash | x | x | ||
Rash | Rash | x | x | ||
Nodule | Nodule | x | x | ||
Pain | Pain | x | x | ||
Stinging | x | x | |||
Dyshidrotic eczema | Dyshidrotic eczema | x | x | ||
Dermatitis contact | Allergic contact dermatitis | x | x | ||
Papule | Papule | x | x | ||
Paraesthesia | Tingling sensation | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||
---|---|---|---|---|---|
Body tinea | x | x | |||
Infection | x | x | |||
Pityriasis | x | x | |||
Tinea cruris | x | x | |||
Tinea infection | x | x | |||
Tinea pedis | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |